Priority Date: 29.05.12 (US 201261652711P)

DNA MODIFYING FUSION PROTEINS AND METHODS OF USE THEREOF

  • Application ID: EP13797024
  • Status: GRANT OF PATENT INTENDED

Applicant

Attorney

operating since 1884
Headquarter in Birmingham and 5 offices
active in Legal Services and IP Consulting

Specialization

This patent has the IPC combination A61, C07, and C12 Forresters IP LLP is specialized in the combination A61, C07, and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 127 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 29.05.2012 - Priority Date (US 201261652711P)
  • 05.12.2013 - Publication A1 (WO2013181228)
  • 10.06.2015 - Publication A1 (EP2879693)